The Geneva Health Forum, together with the Institute of Global Health of the University of Geneva, the Swiss Tropical and Public Health Institute (Swiss TPH) and the Centre for Applied Human Rights at the University of York are inviting you to an online session that will present the first findings of a Geneva Health Forum workshop initiated in the framework of the Noma Project.
Noma (cancrum oris) is a gangrenous disease which destroys the soft and hard facial tissues. It predominantly affects children aged 2-6 years living in extreme poverty. With a high mortality rate of up to 90 per cent, noma leaves survivors with significant aesthetic and functional sequelae, suffering intense social isolation, stigmatisation and discrimination.
The Noma Project is a collaborative undertaking among researchers from various universities, benefitting from the support of non-, inter- and governmental partners. In an effort to achieve greater understanding of noma and engender action to prevent, detect and treat this disease and redress the associated human rights violations, the Noma Project seeks to:
- Establish noma’s epidemiology & global burden;
- Portray the realities & lived experiences of child and adult noma survivors, and
- Evaluate the implications of the framing of noma as a human rights issue & neglected tropical disease.
During this session, researchers involved in the Noma Project will be presenting preliminary findings of a systematic literature review on noma, legal analysis, and in-country fieldwork in Burkina Faso and Niger.
We invite you to an interactive discussion with our researchers with the aim to explore modalities of generating scholarly and social impact relating to noma.
The panel will be chaired by Professor Emmanuel Kabengele Mpinga from the Institute of Global Health, University of Geneva.
Questions & answers will be moderated by Dr Ioana Cismas from the Centre for Applied Human Rights & York Law School.For more information and registration, visit our website. See website of The Noma Project. To register, click here.